2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

L. Samuel Wann; Anne B. Curtis; Kenneth A. Ellenbogen; N. A.Mark Estes; Michael D. Ezekowitz; Warren M. Jackman; Craig T. January; James E. Lowe; Richard L. Page; David J. Slotwiner; William G. Stevenson; Cynthia M. Tracy; Valentin Fuster; Lars E. Rydn; David S. Cannom; Harry J. Crijns; Jonathan L. Halperin; G. Neal Kay; Jean Yves Le Heuzey; S. Bertil Olsson; Eric N. Prystowsky; Juan Luis Tamargo; Alice K. Jacobs; Jeffrey L. Anderson; Nancy Albert; Mark A. Creager; Steven M. Ettinger; Robert A. Guyton; Judith S. Hochman; Frederick G. Kushner; Erik Magnus Ohman; Clyde W. Yancy

doi:10.1016/j.hrthm.2011.01.032

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

L. Samuel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, N. A.Mark Estes, Michael D. Ezekowitz, Warren M. Jackman, Craig T. January, James E. Lowe, Richard L. Page, David J. Slotwiner, William G. Stevenson, Cynthia M. Tracy, Valentin Fuster, Lars E. Rydn, David S. Cannom, Harry J. Crijns, Jonathan L. Halperin, G. Neal Kay, Jean Yves Le Heuzey, S. Bertil OlssonEric N. Prystowsky, Juan Luis Tamargo, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Judith S. Hochman, Frederick G. Kushner, Erik Magnus Ohman, Clyde W. Yancy

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Original language	English (US)
Pages (from-to)	e1-e8
Journal	Heart Rhythm
Volume	8
Issue number	3
DOIs	https://doi.org/10.1016/j.hrthm.2011.01.032
State	Published - Mar 2011

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.hrthm.2011.01.032

Cite this

Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., Stevenson, W. G., Tracy, C. M., Fuster, V., Rydn, L. E., Cannom, D. S., Crijns, H. J., Halperin, J. L., Kay, G. N., Le Heuzey, J. Y., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm, 8(3), e1-e8. https://doi.org/10.1016/j.hrthm.2011.01.032

@article{4fbfcfc0e35a4c1fa05414dd487d6013,

title = "2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines",

author = "Wann, {L. Samuel} and Curtis, {Anne B.} and Ellenbogen, {Kenneth A.} and Estes, {N. A.Mark} and Ezekowitz, {Michael D.} and Jackman, {Warren M.} and January, {Craig T.} and Lowe, {James E.} and Page, {Richard L.} and Slotwiner, {David J.} and Stevenson, {William G.} and Tracy, {Cynthia M.} and Valentin Fuster and Rydn, {Lars E.} and Cannom, {David S.} and Crijns, {Harry J.} and Halperin, {Jonathan L.} and Kay, {G. Neal} and {Le Heuzey}, {Jean Yves} and Olsson, {S. Bertil} and Prystowsky, {Eric N.} and Tamargo, {Juan Luis} and Jacobs, {Alice K.} and Anderson, {Jeffrey L.} and Nancy Albert and Creager, {Mark A.} and Ettinger, {Steven M.} and Guyton, {Robert A.} and Hochman, {Judith S.} and Kushner, {Frederick G.} and Ohman, {Erik Magnus} and Yancy, {Clyde W.}",

note = "Funding Information: The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of relationships with industry and other entities (RWI) among the writing group. Specifically, all members of the writing group, as well as peer reviewers of the document, are asked to disclose all current relationships and those existing 12 months before initiation of the writing effort. In response to implementation of a newly revised RWI policy approved by the ACC and AHA, it is also required that the writing group chair plus a majority of the writing group (50%) have no Members must recuse themselves from voting on any recommendation to which their RWI apply. Any writing group member who develops a new RWI during his or her tenure is required to notify guideline staff in writing. These statements are reviewed by the Task Force and all members during each conference call and/or meeting of the writing group and are updated as changes occur. For detailed information about guideline policies and procedures, please refer to the ACCF/AHA methodology and policies manual. respectively. In addition, to ensure complete transparency, writing group members' relevant RWI. All guideline recommendations require a confidential vote by the writing group and must be approved by a consensus of the members voting. Members who were recused from voting are noted on the title page of this document and in Appendix 1 . 1 Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2 , comprehensive disclosure information —including RWI not pertinent to this document—is available online as a supplement to this document. Disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-Task-Forces.aspx . The work of the writing group was supported exclusively by the ACCF and AHA and Heart Rhythm Society (HRS) without commercial support. Writing group members volunteered their time for this effort. ",

year = "2011",

month = mar,

doi = "10.1016/j.hrthm.2011.01.032",

language = "English (US)",

volume = "8",

pages = "e1--e8",

journal = "Heart Rhythm",

issn = "1547-5271",

publisher = "Elsevier",

number = "3",

}

Wann, LS, Curtis, AB, Ellenbogen, KA, Estes, NAM, Ezekowitz, MD, Jackman, WM, January, CT, Lowe, JE, Page, RL, Slotwiner, DJ, Stevenson, WG, Tracy, CM, Fuster, V, Rydn, LE, Cannom, DS, Crijns, HJ, Halperin, JL, Kay, GN, Le Heuzey, JY, Olsson, SB, Prystowsky, EN, Tamargo, JL, Jacobs, AK, Anderson, JL, Albert, N, Creager, MA, Ettinger, SM, Guyton, RA, Hochman, JS, Kushner, FG, Ohman, EM & Yancy, CW 2011, '2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines', Heart Rhythm, vol. 8, no. 3, pp. e1-e8. https://doi.org/10.1016/j.hrthm.2011.01.032

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran) : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. / Wann, L. Samuel; Curtis, Anne B.; Ellenbogen, Kenneth A. et al.

In: Heart Rhythm, Vol. 8, No. 3, 03.2011, p. e1-e8.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran)

T2 - A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

AU - Wann, L. Samuel

AU - Curtis, Anne B.

AU - Ellenbogen, Kenneth A.

AU - Estes, N. A.Mark

AU - Ezekowitz, Michael D.

AU - Jackman, Warren M.

AU - January, Craig T.

AU - Lowe, James E.

AU - Page, Richard L.

AU - Slotwiner, David J.

AU - Stevenson, William G.

AU - Tracy, Cynthia M.

AU - Fuster, Valentin

AU - Rydn, Lars E.

AU - Cannom, David S.

AU - Crijns, Harry J.

AU - Halperin, Jonathan L.

AU - Kay, G. Neal

AU - Le Heuzey, Jean Yves

AU - Olsson, S. Bertil

AU - Prystowsky, Eric N.

AU - Tamargo, Juan Luis

AU - Jacobs, Alice K.

AU - Anderson, Jeffrey L.

AU - Albert, Nancy

AU - Creager, Mark A.

AU - Ettinger, Steven M.

AU - Guyton, Robert A.

AU - Hochman, Judith S.

AU - Kushner, Frederick G.

AU - Ohman, Erik Magnus

AU - Yancy, Clyde W.

N1 - Funding Information: The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of relationships with industry and other entities (RWI) among the writing group. Specifically, all members of the writing group, as well as peer reviewers of the document, are asked to disclose all current relationships and those existing 12 months before initiation of the writing effort. In response to implementation of a newly revised RWI policy approved by the ACC and AHA, it is also required that the writing group chair plus a majority of the writing group (50%) have no Members must recuse themselves from voting on any recommendation to which their RWI apply. Any writing group member who develops a new RWI during his or her tenure is required to notify guideline staff in writing. These statements are reviewed by the Task Force and all members during each conference call and/or meeting of the writing group and are updated as changes occur. For detailed information about guideline policies and procedures, please refer to the ACCF/AHA methodology and policies manual. respectively. In addition, to ensure complete transparency, writing group members' relevant RWI. All guideline recommendations require a confidential vote by the writing group and must be approved by a consensus of the members voting. Members who were recused from voting are noted on the title page of this document and in Appendix 1 . 1 Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2 , comprehensive disclosure information —including RWI not pertinent to this document—is available online as a supplement to this document. Disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-Task-Forces.aspx . The work of the writing group was supported exclusively by the ACCF and AHA and Heart Rhythm Society (HRS) without commercial support. Writing group members volunteered their time for this effort.

PY - 2011/3

Y1 - 2011/3

UR - http://www.scopus.com/inward/record.url?scp=79952187886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952187886&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2011.01.032

DO - 10.1016/j.hrthm.2011.01.032

M3 - Article

C2 - 21324421

AN - SCOPUS:79952187886

VL - 8

SP - e1-e8

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 3

ER -

Wann LS, Curtis AB, Ellenbogen KA, Estes NAM, Ezekowitz MD, Jackman WM et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Mar;8(3):e1-e8. doi: 10.1016/j.hrthm.2011.01.032

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this